TRPV1 and psoriasis: The abnormal activation of TRPV1/TRPA1 channels can result in pruritus and hyperalgesia, and accounts for the clinical phenomena experienced by approximately 60%-90% of patients with psoriasis, such as itching, skin pain, and discomfort (6, 7).